Antares Pharma Inc (NASDAQ:ATRS)

4.46
Delayed Data
As of 4:00pm ET
 +0.09 / +2.06%
Today’s Change
2.55
Today|||52-Week Range
5.07
+11.78%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 5.00. The median estimate represents a +56.95% increase from the last price of 4.46.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.02
Sales
$43.3M
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -14.29%
 
 
 
 
 
 
Growthannually -64.94%
 
 
 
 
 
 

Sales

Growthquarterly 2.80%
 
 
 
 
 
 
Growthannually 26.26%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.